← Back to Search

Behavioural Intervention

TENS Active Treatment for Overweight

N/A
Waitlist Available
Research Sponsored by Elira, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months

Summary

This trial tests if the Elira System, which uses gentle electrical signals to help control appetite, combined with a moderate exercise and diet program, can help overweight and mildly obese people manage their weight better.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
A difference in Percent Total Body Weight Loss (%TBWL)
A responder rate of at least 35% in the active treatment
Secondary study objectives
Changes in BMI
Changes in appetite as measured by Appetite Visual Analogue Scale (VAS)
Changes in eating behaviors as measured by TFEQ scores
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: TENS Active TreatmentExperimental Treatment1 Intervention
Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Management (The Elira System)
Group II: Sham Control DevicePlacebo Group1 Intervention
Sham TENS unit that provides no actual therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TENS Active Treatment
2022
N/A
~400

Find a Location

Who is running the clinical trial?

Elira, Inc.Lead Sponsor

Media Library

Elira System (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05675384 — N/A
Overweight Research Study Groups: Sham Control Device, TENS Active Treatment
Overweight Clinical Trial 2023: Elira System Highlights & Side Effects. Trial Name: NCT05675384 — N/A
Elira System (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05675384 — N/A
~122 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top